Ustekinumab is effective against ulcerative colitis with intestinal stenosis: A case report.
Medicine(2022)
Abstract
UST is effective against UC with benign intestinal stenosis. It is thought that UST inhibits the production of transforming growth factor-β and interleukin-17, leading to the suppression of myofibroblast proliferation, ultimately alleviating intestinal stenosis.
MoreTranslated text
Key words
benign intestinal stenosis, fibrosis, ulcerative colitis, ustekinumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined